STOCK TITAN

Organigram to Report Fourth Quarter and Fiscal 2023 Results on December 19, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Organigram Holdings Inc. (OGI) to Report Q4 and Fiscal 2023 Earnings Results on December 19, 2023
Positive
  • None.
Negative
  • None.

TORONTO--(BUSINESS WIRE)-- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2023 ended September 30, 2023, on Tuesday, December 19, 2023, before market open.

The Company will host a conference call to discuss its results with details as follows:

Date: Tuesday, December 19, 2023
Time: 8:00 am Eastern Time

To register for the conference call, please use this link:
https://conferencingportals.com/event/XWQpOvKk

To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call.

To access the webcast:
https://events.q4inc.com/attendee/990999128
Participants will receive their details via email.

A replay of the webcast will be available within 24 hours after the conclusion of the call at https://www.organigram.ca/investors and will be archived for a period of 90 days following the call.

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly-owned subsidiaries include: Organigram Inc. a licensed producer of cannabis, cannabis-derived products and cannabis infused edibles in Canada. Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Big Bag O’ Buds, SHRED, SHRED’ems, Holy Mountain, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

For media enquiries:

Paolo De Luca

Interim Chief Financial Officer and Chief Strategy Officer

paolo.deluca@organigram.ca

For investor enquiries:

Max Schwartz

Director of Investor Relations

investors@organigram.ca

Source: Organigram Holdings Inc.

FAQ

When will Organigram Holdings Inc. (OGI) report its Q4 and fiscal 2023 earnings results?

Organigram Holdings Inc. (OGI) will report its Q4 and fiscal 2023 earnings results on Tuesday, December 19, 2023, before market open.

What time will the conference call to discuss Organigram Holdings Inc. (OGI) results take place?

The conference call to discuss Organigram Holdings Inc. (OGI) results will take place at 8:00 am Eastern Time on Tuesday, December 19, 2023.

How can I register for the conference call to discuss Organigram Holdings Inc. (OGI) results?

To register for the conference call, please use this link: https://conferencingportals.com/event/XWQpOvKk. Registration is open through the live call.

Where can I access the webcast of Organigram Holdings Inc. (OGI) results discussion?

To access the webcast, please visit https://events.q4inc.com/attendee/990999128. Participants will receive their details via email.

Will there be a replay of the webcast for Organigram Holdings Inc. (OGI) results discussion?

Yes, a replay of the webcast will be available within 24 hours after the conclusion of the call at https://www.organigram.ca/investors and will be archived for a period of 90 days following the call.

Organigram Holdings Inc.

NASDAQ:OGI

OGI Rankings

OGI Latest News

OGI Stock Data

157.07M
75.21M
27.32%
14.87%
4.1%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
Toronto